HIV testing is crucial before starting or restarting PrEP to identify any existing infections and prevent drug resistance. For both daily and event-driven PrEP users, HIV testing is recommended every three months, ideally coinciding with prescription refills. There are concerns regarding the risk of drug resistance with event-driven PrEP due to potential gaps in HIV testing.
HIV testing is crucial before starting or restarting PrEP to identify any existing infections and prevent drug resistance. For both daily and event-driven PrEP users, HIV testing is recommended every three months, ideally coinciding with prescription refills. There are concerns regarding the risk of drug resistance with event-driven PrEP due to potential gaps in HIV testing.
HIV testing is crucial before starting or restarting PrEP to identify any existing infections and prevent drug resistance. For both daily and event-driven PrEP users, HIV testing is recommended every three months, ideally coinciding with prescription refills. There are concerns regarding the risk of drug resistance with event-driven PrEP due to potential gaps in HIV testing.
HIV testing is crucial before starting or restarting PrEP to identify any existing infections and prevent drug resistance. For both daily and event-driven PrEP users, HIV testing is recommended every three months, ideally coinciding with prescription refills. There are concerns regarding the risk of drug resistance with event-driven PrEP due to potential gaps in HIV testing.
“PrEP is not sufficient for the treatment of HIV infection. HIV testing before starting or restarting PrEP is essential to detect infections that require treatment. If PrEP is stopped, an HIV test should be obtained before restarting it. Use of PrEP in people who already have HIV infection can lead to development of resistance to PrEP medicines.” WHO Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 1: Clinical. Geneva: World Health Organization; 2017 (WHO/HIV/2017.17). Licence: CC BY- NC-SA 3.0 IGO.
RELATED TO EVENT-DRIVEN PREP
“Monitoring visits and HIV testing and other laboratory testing for people taking PrEP should be the same whether they take oral daily PrEP or event-driven PrEP. See the clinical module (Module 1) in the WHO PrEP Implementation Tool (7). However, a man taking ED-PrEP infrequently may not always need a new PrEP prescription as often as every three months, or may be prescribed fewer bottles of PrEP. If that might be the case, counselling should specifically emphasize testing for HIV every three months.” “HIV testing is recommended every three months both for people taking daily oral and for those taking ED-PrEP, usually coinciding with clients collecting their next prescription for PrEP drugs. Some clinicians have raised concerns that drug resistance risk may be higher with ED-PrEP because drug exposure is episodic and HIV testing may not occur before PrEP use. People taking ED-PrEP infrequently may theoretically become HIV infected in periods where they are off PrEP, with subsequent increased risk of resistance if ED-PrEP is taken without prior HIV testing ruling out HIV infection.” What’s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: Update to WHO’s recommendation on oral PrEP. Geneva: World Health Organization; 2019 (WHO/CDS/HIV/19.8). Licence CC BY-NC-SA 3.0 IGO.